We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Equal Health's (EH) mission is to create a healthy organic food brand that makes a difference to the environment and its customers' health. The company wants to become the go-to brand for healthy organic meals. EH uses seasonal organic ingredients which are ethically sourced, cooked and packed in its kitchen by its expert team of chefs. It received its organic status through the UK's leading certification body, The Soil Association. It aims to launch a new range of healthy organic frozen meals. EH will use the investment to focus on digital marketing, increase its kitchen facilities, and invest in New Product Development (NPD).

Pitch Rated

43%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £226,598
L'orchidee is a boutique patisserie concept that specialises in macaroons and cakes for all occasions. L'orchidee currently have 3 stores with their most successful store recently opening in Canary Wharf. 
days to go: Expired investment: £33,480
Nutrifix is an app that locates healthy meals nearby or selects recipes or delivery options all tailored to you bodies needs. The app is like having a personal nutritionist in your pocket and is in a growing sector as the global value of mobile health solutions is set to reach 83,000,000,000 by 2022.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £194,310
ShareProperty is a property crowdfunding platform that allows you, the investor to select your investment according to your own risk profile and required rate of return. ShareProperty allows you to build and manage your own property portfolio, hold your investment to term or resell on the ShareProperty trading exchange.
days to go: Expired investment: £149,002
Smoke & Salt is an award-winning, critically acclaimed restaurant that combines the idea for contemporary dining with ancient food storage methods. It is the first restaurant from Smoke & Salt Hospitality Group Ltd and has won many awards including The Cateys ‘Best Newcomer’ restaurant, a 5-star review from Time Out, and it was put 6th on the ‘Top 100 restaurants in London that you have to try’ list. The funds will be used to secure the restaurant site, buy the equipment, fund the fit-out and working capital for the company.
days to go: Expired investment: £154,225
Poppy’s Picnic produces fresh raw dog food, handmade in the heart of Wiltshire, using quality local ingredients. Within a year of going online in Oct 16, it grew sales from £7k-£50k pm and started exporting to Hong Kong. Funds will be used to launch a cat food range and expand its dog food offering
days to go: Expired investment: £577,180
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph